We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Synthetic Screws Enhance Musculoskeletal Tissue Repair

By HospiMedica International staff writers
Posted on 02 Nov 2020
An innovative bioresorbable tendon interference screw system with biological and biomechanical benefits aids tissue attachment during orthopedic procedures.

The Acuitive Technologies (Allendale, NJ, USA) CITRELOCK Interference Screw System is intended to reattach musculoskeletal host tissue during orthopedic surgeries, such as fixation of ligaments or tendon graft tissue repairs of the shoulder, elbow, wrist, hand, knee, ankle, and foot extremities. More...
The system, which is based on proprietary Citregen, a thermoset bioresorbable synthetic polymer made of citrate, a natural anti-microbial and anti-inflammatory molecule that plays a crucial role in bone regeneration by regulating cellular metabolic processes and the formation of mineral structures.

Designed on the molecular level, Citregen guides tissue regeneration by replicating the body’s intrinsic cellular biochemical and structural support network, releasing molecules essential for bone formation throughout its bioresorption, leaving behind a biomimetic ceramic structure to be metabolized by the host tissue. This avoids the potential for bulk degradation and chronic inflammation seen in currently available biodegradable polymers. CITRELOCK is available with both reusable surgical instruments and single-use instruments, and in a full range of device sizes.

“Citregen is based on an unprecedented and innovative bioresorbable biomaterial technology developed to support the body's normal healing processes and promote tissue regeneration,” said Professor Guillermo Ameer, ScD, founding director of the Center for Advanced Regenerative Engineering at Northwestern University (Chicago, IL, USA). “When used to fabricate devices for reconstruction of tissues such as ligaments, blood vessels, bladder and bone, results have been impressive and beyond expectations.”

About 90% of the total citrate in the body is in the bones, which function as its major reservoir. In the bone, citrate is synthesized and excreted by osteoblasts, and it is an important component (1%) of bone apatite crystals. Citrate is released to into plasma during bone resorption.



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.